Skip to main content

Table 1 Summary of blood purifications

From: Methotrexate-induced acute kidney injury in patients with hematological malignancies: three case reports with literature review

  Case 1 Case 2 Case 3
HD
 Dialysis treatment time 3 h 3 h 3 h
 Dialyzer APS®-13 SA APS®-13SA APS®-11SA
 Blood flow 150 ml/min 150 ml/min 150 ml/min
 Total number of times 4 2 4
Plasma exchange
 Plasma separator Plasmaflo®
OP-05 W 		Plasmaflo®
OP-05 W 		Plasmaflo®
OP-05 W
 Replacement fluid FFP 2880 ml 5%albumin 2000 ml FFP 2880 ml
5%albumin 2000 ml
 Total number of times 8 2 FFP 4, albumin 3
Hemoadsorption
 Treatment time   3.5 h  
 Device   Hemosorba®CHS350  
 Total number of times   1  
  1. HD hemodialysis, FFP fresh frozen plasma
  2. APS®-11SA (Asahi Kasei Kuraray Medical Co. Ltd., Tokyo, Japan; Polysulfone, 1.1 m2)
  3. APS®-13SA (Asahi Kasei Kuraray Medical Co. Ltd., Tokyo, Japan; Polysulfone, 1.3 m2)
  4. Plasmaflo® OP-05 W (Asahi Kasei Kuraray Medical Co. Ltd., Tokyo, Japan; Polyethylene, 0.5 m2, Maximum Pore Size 0.3 μm)
  5. Hemosorba® CH-350 (Asahi Kasei Kuraray Medical Co. Ltd.)
Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us